ASXL1 and chronic myelomonocytic leukemia: We confirmed the negative prognostic effects of RUNX1, NRAS, and SETBP1 mutations in CMML patients through univariate analysis, but we did not find any prognostic significance for ASXL1 and TET2 mutations.